BioSpace News Archive

Computational biology has emerged as a discipline in its own right and has enriched the armamentarium of researchers studying molecular mechanism underlying wide range of diseases.

The development of the global general laboratory equipment market is anticipated to be influenced by increased research activities in biotechnological and pharmaceutical industries.

Takeda Pharmaceutical Company Limited announced that it has completed the previously announced sale of TachoSil® Fibrin Sealant Patch to Corza Health, Inc. for €350 million.

Orexo AB, has mandated ABG Sundal Collier AB to arrange a series of fixed income investor meetings in the Nordics, commencing on 1 February 2021.

Vicore Pharma Holding AB, a pharmaceutical company dedicated to developing innovative medicines for severe lung disorders, published data from the phase II study ATTRACT online and submitted it to a peer reviewed journal.

GN Hearing, the global leader in hearing aid innovation, unveils ReSound Key, a full essential hearing aid line-up that provides greater access to proven and award-winning hearing technology worldwide.

Coherus to pay $150 million upfront for U.S. and Canada rights to toripalimab, an extensively studied, late-stage anti-PD-1 antibody

Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company focused on developing next generation therapeutics to advance standards of care in areas of significant unmet medical need, announced topline results from the ENHANCE-IT study, the second head-to-head comparative study of LYPDISO™ vs. Vascepa®.

Thermo Fisher Scientific Inc., the world leader in serving science, reported its financial results for the fourth quarter and full year ended December 31, 2020.

Advanced intelligent Clear-IQ Engine (AiCE) Deep Learning Reconstruction (DLR) Technology Expands to Wider Range of Clinical Applications for the Vantage Orian 1.5T MR System